Capricor Therapeutics Inc to Host Key Opinion Leader (KOL) Call Transcript
Greetings and welcome to the Key Opinion Leader call why exosomes are uniquely suited for vaccine development hosted by Capricor Therapeutics. (Operator Instructions) As a reminder, this conference is being recorded.
I would now like to turn the conference over to your host, AJ Bergmann, Chief Financial Officer, for Capricor Therapeutics. Thank you. You may begin.
Thank you and thank you for joining our call. Before we start, I would like to state that we will be making certain forward-looking statements during today's presentation. These statements may include statements regarding among other things, the efficacy, safety, and intended utilization of our product candidates, our future research and development plans including our anticipated conduct, timing of preclinical and clinical studies, our plans to present or report additional data, our plans regarding regulatory filings, potential regulatory developments involving our product candidates and our (technical difficulty) and investment resources.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |